Search

Your search keyword '"Jolly AM"' showing total 44 results

Search Constraints

Start Over You searched for: Author "Jolly AM" Remove constraint Author: "Jolly AM"
44 results on '"Jolly AM"'

Search Results

1. Sequencing and Analysis of Lumpy Skin Disease Virus Whole Genomes Reveals a New Viral Subgroup in West and Central Africa

2. A survey of contagious ecthyma and molecular characterization of Orf virus in sheep and goats in Nigeria (2014-2016)

4. Poxvirus Infections in Dairy Farms and Transhumance Cattle Herds in Nigeria

5. Co‐infection of peste des petits ruminants and goatpox in a mixed flock of sheep and goats in Kanam, North Central Nigeria

6. First report of camel contagious ecthyma in Nigeria

7. Social network-related risk factors for bloodborne virus infections among injection drug users receiving syringes through secondary exchange.

9. Prevalence and correlates of Chlamydia infection in Canadian street youth.

10. Chronic kidney disease of unknown etiology in India: a comparative study with Mesoamerican and Sri Lankan nephropathy.

12. The development of respondent-driven sampling (RDS) inference: A systematic review of the population mean and variance estimates.

13. The Sociospatial Network: Risk and the Role of Place in the Transmission of Infectious Diseases.

15. Social network investigation of a syphilis outbreak in Ottawa, Ontario.

16. Outlier populations: individual and social network correlates of solvent-using injection drug users.

17. Understanding recruitment: outcomes associated with alternate methods for seed selection in respondent driven sampling.

18. STI phase and the geography of sexual partnerships: prevalence of long-distance sexual contacts among chlamydia, gonorrhea, and coinfected STI cases in Manitoba, Canada.

19. Transmission patterns of HIV and hepatitis C virus among networks of people who inject drugs.

20. Increased risk for hepatitis C associated with solvent use among Canadian Aboriginal injection drug users.

21. Discovery of 6-aryl-7-alkoxyisoquinoline inhibitors of IkappaB kinase-beta (IKK-beta).

22. Comparison of Neisseria gonorrhoeae multiantigen sequence typing and porB sequence analysis for identification of clusters of N. gonorrhoeae isolates.

23. HIV and HCV discordant injecting partners and their association to drug equipment sharing.

24. Identifying heterogeneity among injection drug users: a cluster analysis approach.

25. Clusters of circulating Neisseria gonorrhoeae strains and association with antimicrobial resistance in Shanghai.

26. Combining social network analysis and cluster analysis to identify sexual network types.

27. Rethinking approaches to risk reduction for injection drug users: differences in drug type affect risk for HIV and hepatitis C virus infection through drug-injecting networks.

28. The importance of social networks in their association to drug equipment sharing among injection drug users: a review.

29. Determinants of injection drug user (IDU) syringe sharing: the relationship between availability of syringes and risk network member characteristics in Winnipeg, Canada.

30. Conducting HIV/AIDS research with indoor commercial sex workers: reaching a hidden population.

31. Antimicrobial susceptibility and molecular determinants of quinolone resistance in Neisseria gonorrhoeae isolates from Shanghai.

32. Demographic, risk behaviour and personal network variables associated with prevalent hepatitis C, hepatitis B, and HIV infection in injection drug users in Winnipeg, Canada.

33. Sexually transmitted disease thresholds in Manitoba, Canada.

34. Identification of networks of sexually transmitted infection: a molecular, geographic, and social network analysis.

35. Sexual network analysis of a gonorrhoea outbreak.

36. Changing virulence of the SARS virus: the epidemiological evidence.

37. Chlamydia trachomatis omp1 genotypic diversity and concordance with sexual network data.

38. Gonorrhoea and chlamydia core groups and sexual networks in Manitoba.

39. Sexual networks and sexually transmitted infections: a tale of two cities.

40. Sampling individuals with large sexual networks: an evaluation of four approaches.

41. Risk factors for infection in women undergoing testing for Chlamydia trachomatis and Neisseria gonorrhoeae in Manitoba, Canada.

43. Polymers for biodegradable medical devices. II. Hydroxybutyrate-hydroxyvalerate copolymers: hydrolytic degradation studies.

44. Polymers for biodegradable medical devices. VI. Hydroxybutyrate-hydroxyvalerate copolymers: accelerated degradation of blends with polysaccharides.

Catalog

Books, media, physical & digital resources